• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在日本,由于低价值医疗,低成本、高量的医疗服务导致了不必要医疗支出的最大占比。

Low-Cost, High-Volume Health Services Contribute the Most to Unnecessary Health Spending due to Low-Value Care in Japan.

作者信息

Miyawaki Atsushi, Mafi John N, Fukui Tsuguya, Kimura Yuya, Kobayashi Daiki, Odawara Sara, Abe Kazuhiro, Goto Rei, Tsugawa Yusuke

机构信息

Public Health Research Group, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.

出版信息

medRxiv. 2025 Aug 26:2025.08.21.25334207. doi: 10.1101/2025.08.21.25334207.

DOI:10.1101/2025.08.21.25334207
PMID:40909821
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12407603/
Abstract

IMPORTANCE

As healthcare costs continue to rise, high-income countries-including Japan-face the urgent task of reducing healthcare spending incurred by low-value care. However, evidence is limited as to which low-value care services contribute most to unnecessary healthcare spending outside of the United States.

OBJECTIVE

To identify which low-value care services contribute the most to unnecessary healthcare spending in Japan.

DESIGN SETTING AND PARTICIPANTS

The cross-sectional study of all beneficiaries using a population-based claims database from April 1, 2022, to March 31, 2023, encompassing all age groups, reflecting approximately 2% of the total Japanese population.

MAIN OUTCOMES AND MEASURES

We identified 52 low-value care services based on clinical evidence, and examined their contributions to healthcare spending using two versions of claims-based measures with different sensitivities and specificities (broader and narrower definitions). Each service was categorized into four groups based on its average per-service price: very low (<1,000 Japanese yen [JPY] = 8 US dollars [USD] in 2022), low (1,000-9,999 JPY), medium (10,000-99,999 JPY), or high (≥100,000 JPY).

RESULTS

Among 1,923,484 beneficiaries (mean [SD] age 58.6 [23.5] years; 52.7% female), we identified 3.1 million (narrower definition) to 3.7 million (broader definition) episodes of low-value care services (1.6-1.9 per capita), with 36-40% of patients receiving at least one low-value care service. These services accounted for 0.7-1.0% of total healthcare spending, amounting to 207-331 billion JPY (1.7-2.6 billion USD) when extrapolated nationwide with adjustments for age, sex, and region. When applying narrower definitions, over 99% of low-value care episodes involved very-low-cost or low-cost services, which accounted for 67% of unnecessary healthcare spending-far exceeding the 33% attributed to medium-cost or high-cost services.

CONCLUSION AND RELEVANCE

Over one in three Japanese individuals received low-value care during 2022-2023, contributing to 0.7-1.0% of total healthcare spending. Among these services, low-cost services contributed to virtually all low-value care utilization and over two-thirds of unnecessary healthcare spending. Compared to focusing solely on high-cost services, targeting the reduction of frequently performed, lower-cost services may be a more effective strategy for reducing wasteful spending.

摘要

重要性

随着医疗成本持续上升,包括日本在内的高收入国家面临着减少低价值医疗所产生的医疗支出这一紧迫任务。然而,在美国以外,关于哪些低价值医疗服务对不必要的医疗支出贡献最大的证据有限。

目的

确定在日本,哪些低价值医疗服务对不必要的医疗支出贡献最大。

设计、设置和参与者:一项横断面研究,研究对象为2022年4月1日至2023年3月31日期间使用基于人群的理赔数据库的所有受益人,涵盖所有年龄组,约占日本总人口的2%。

主要结局和衡量指标

我们基于临床证据确定了52项低价值医疗服务,并使用两种具有不同敏感性和特异性的基于理赔的衡量指标版本(更宽泛和更狭义的定义)来研究它们对医疗支出的贡献。每项服务根据其每项服务的平均价格分为四组:极低(<1000日元[2022年相当于8美元])、低(1000 - 9999日元)、中(10000 - 99999日元)或高(≥100000日元)。

结果

在1923484名受益人中(平均[标准差]年龄58.6[23.5]岁;52.7%为女性),我们确定了310万(狭义定义)至370万(广义定义)例低价值医疗服务事件(人均1.6 - 1.9例),36% - 40%的患者接受了至少一项低价值医疗服务。这些服务占医疗总支出的0.7% - 1.0%,在对年龄、性别和地区进行调整后推算至全国范围时,金额达2070亿 - 3310亿日元(17亿 - 26亿美元)。采用狭义定义时,超过99%的低价值医疗事件涉及极低成本或低成本服务,这些服务占不必要医疗支出的67%,远远超过中成本或高成本服务所占的33%。

结论及意义

在2022 - 2023年期间,超过三分之一的日本人接受了低价值医疗,占医疗总支出的0.7% - 1.0%。在这些服务中,低成本服务几乎构成了所有低价值医疗的使用情况以及超过三分之二的不必要医疗支出。与仅关注高成本服务相比,针对减少频繁进行的低成本服务可能是减少浪费性支出的更有效策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b78/12407603/01fc41239d0d/nihpp-2025.08.21.25334207v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b78/12407603/86f447bf0d41/nihpp-2025.08.21.25334207v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b78/12407603/01fc41239d0d/nihpp-2025.08.21.25334207v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b78/12407603/86f447bf0d41/nihpp-2025.08.21.25334207v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b78/12407603/01fc41239d0d/nihpp-2025.08.21.25334207v1-f0002.jpg

相似文献

1
Low-Cost, High-Volume Health Services Contribute the Most to Unnecessary Health Spending due to Low-Value Care in Japan.在日本,由于低价值医疗,低成本、高量的医疗服务导致了不必要医疗支出的最大占比。
medRxiv. 2025 Aug 26:2025.08.21.25334207. doi: 10.1101/2025.08.21.25334207.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Sexual Harassment and Prevention Training性骚扰与预防培训
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
6
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
7
Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low- and middle-income countries.无条件现金转移以减少贫困和脆弱性:对中低收入国家卫生服务利用和健康结果的影响。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD011135. doi: 10.1002/14651858.CD011135.pub3.
8
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
9
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
10
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预:针对慢性阻塞性肺疾病(COPD)患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.

本文引用的文献

1
Projected Savings From Reducing Low-Value Services in Medicare.医疗保险中减少低价值服务预计节省的费用。
JAMA Health Forum. 2025 Aug 1;6(8):e253050. doi: 10.1001/jamahealthforum.2025.3050.
2
Primary Care Physician Characteristics and Low-Value Care Provision in Japan.日本基层医疗医生的特征与低价值医疗服务提供情况
JAMA Health Forum. 2025 Jun 7;6(6):e251430. doi: 10.1001/jamahealthforum.2025.1430.
3
DeSC database.DeSC数据库。
Ann Clin Epidemiol. 2025 Jan 7;7(2):46-49. doi: 10.37737/ace.25006. eCollection 2025 Apr 1.
4
Cardiovascular Safety and Fracture Prevention Effectiveness of Denosumab Versus Oral Bisphosphonates in Patients Receiving Dialysis : A Target Trial Emulation.地诺单抗与口服双膦酸盐在接受透析患者中的心血管安全性及骨折预防有效性:一项目标试验模拟研究
Ann Intern Med. 2025 Feb;178(2):167-176. doi: 10.7326/ANNALS-24-03237. Epub 2025 Jan 7.
5
Increased spending on low-value care during the COVID-19 pandemic in Virginia.弗吉尼亚州在新冠疫情期间低价值医疗支出增加。
Health Aff Sch. 2024 Oct 23;2(11):qxae133. doi: 10.1093/haschl/qxae133. eCollection 2024 Nov.
6
Perspectives on low-value care and barriers to de-implementation among primary care physicians: a multinational survey.基层医疗医生对低价值医疗的看法和去执行障碍:一项多国调查。
BMC Prim Care. 2024 May 9;25(1):159. doi: 10.1186/s12875-024-02382-9.
7
Association Between Vonoprazan and the Risk of Gastric Cancer After Helicobacter pylori Eradication.沃诺拉赞与幽门螺杆菌根除后胃癌风险的关联。
Clin Gastroenterol Hepatol. 2024 Jun;22(6):1217-1225.e6. doi: 10.1016/j.cgh.2024.01.037. Epub 2024 Feb 13.
8
Measuring low-value care in hospital discharge records: evidence from China.利用医院出院记录衡量低价值医疗服务:来自中国的证据。
Lancet Reg Health West Pac. 2023 Aug 31;38:100887. doi: 10.1016/j.lanwpc.2023.100887. eCollection 2023 Sep.
9
Top-down and bottom-up approaches to low-value care.低价值医疗的自上而下和自下而上方法。
BMJ Qual Saf. 2023 Feb;32(2):65-68. doi: 10.1136/bmjqs-2022-014977. Epub 2022 Dec 14.
10
Development of the SPREAD framework to support the scaling of de-implementation strategies: a mixed-methods study.发展 SPREAD 框架以支持消除策略的扩展:一项混合方法研究。
BMJ Open. 2022 Nov 7;12(11):e062902. doi: 10.1136/bmjopen-2022-062902.